AI in drug development is a vague term that might mean many things, and today, Owkin is announcing it has enrolled the first patient in a phase 1 study of OKN4395, its “AI-optimized” candidate for ...
The information regarding the MOU and its potential implications for healthcare technology in Dubai is based on a press release statement. Further developments and the outcomes of the MOU will likely ...
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...
"It's an exciting, groundbreaking technology, and I think ... Trinity Health and University of Michigan Health-West. You can find more information on their website.